Oral Fenbendazole for Cancer Therapy in Humans and Animals
Anticancer Research · 2024-09 · 44 (9) · 3725-3735
DOI: 10.21873/anticanres.17197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, online erschienen am 28.08.2024. Verfasst von Jolie Nguyen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, U.S.A. Hauptthemen laut MEDLINE: Fenbendazole, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, U.S.A.
- Life Science Department, University of Science and Technology of Hanoi, Hanoi, Vietnam.
- Nimni-Cordoba Tissue Engineering and Drug Discovery Lab, Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, CA, U.S.A.
- Nimni-Cordoba Tissue Engineering and Drug Discovery Lab, Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, CA, U.S.A. baxuanho@usc.edu.
Zitieren
APA
Nguyen, J., Nguyen, T. Q., Han, B. O., & Hoang, B. X. (2024). Oral Fenbendazole for Cancer Therapy in Humans and Animals. Anticancer Research, 44(9), 3725-3735. https://doi.org/10.21873/anticanres.17197
Vancouver
Nguyen J, Nguyen TQ, Han BO, Hoang BX. Oral Fenbendazole for Cancer Therapy in Humans and Animals. Anticancer Research. 2024;44(9):3725-3735. doi:10.21873/anticanres.17197
BibTeX
@article{Nguyen2024,
author = {Nguyen, Jolie and Nguyen, Thai Q and Han, B O and Hoang, Ba X},
title = {Oral Fenbendazole for Cancer Therapy in Humans and Animals},
journal = {Anticancer Research},
year = {2024},
volume = {44},
number = {9},
pages = {3725--3735},
doi = {10.21873/anticanres.17197}
}
EUVIMED